Dashboard
1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 0%
- Poor long term growth as Operating profit has grown by an annual rate -190.89% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -13.65
2
Flat results in Jun 24
3
Risky -
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
37.14%
0%
37.14%
6 Months
128.57%
0%
128.57%
1 Year
57.38%
0%
57.38%
2 Years
-34.55%
0%
-34.55%
3 Years
-30.84%
0%
-30.84%
4 Years
-35.69%
0%
-35.69%
5 Years
-37.91%
0%
-37.91%
Avacta Group Plc for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
37.90%
EBIT Growth (5y)
-190.89%
EBIT to Interest (avg)
-13.65
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.92
Sales to Capital Employed (avg)
0.21
Tax Ratio
7.61%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
24.93
EV to EBIT
-7.81
EV to EBITDA
-8.95
EV to Capital Employed
12.60
EV to Sales
10.67
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-161.33%
ROE (Latest)
-470.11%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
23.20
9.70
139.18%
Operating Profit (PBDIT) excl Other Income
-23.00
-22.50
-2.22%
Interest
15.30
2.70
466.67%
Exceptional Items
14.90
-10.10
247.52%
Consolidate Net Profit
-24.90
-39.50
36.96%
Operating Profit Margin (Excl OI)
-1,149.30%
-2,640.90%
149.16%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is 139.18% vs 234.48% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is 36.96% vs -49.62% in Dec 2022
About Avacta Group Plc 
Avacta Group Plc
Miscellaneous
Avacta Group plc is a biotechnology company. Avacta's focus is on its proprietary Affimer technology which is an engineered alternative to antibodies that has application in Life Sciences for diagnostics, therapeutics and general research and development. Affimer technology has been designed to address performance limitations of antibodies. Affimer technology is based on a small protein that can be generated to bind with specificity and affinity to a range of targets to enable diagnostics, research assays and therapeutics. Avacta has a pre-clinical therapeutic development programme with an in-house focus on immuno-oncology and bleeding disorders as well as partnered development programmes. Avacta is commercialising non-therapeutic Affimer reagents through licensing to developers of life sciences research tools and diagnostics.
Company Coordinates 
Company Details
Unit 20, Ash Way , WETHERBY None : LS23 7FA
Registrar Details






